Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCG | P01275 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.32 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.32 |
| ▸ | GCGR | P47871 | 6/20 | 0.32 |
| ▸ | ADCY6 | O43306 | 2/20 | 0.32 |
| ▸ | ADCY3 | O60266 | 2/20 | 0.32 |
| ▸ | ADCY9 | O60503 | 2/20 | 0.32 |
| ▸ | ADCY5 | O95622 | 2/20 | 0.32 |
| ▸ | ADCY8 | P40145 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2647241 | 0.89 | GCGR (0.38) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL6914041 | 0.88 | GCGR (0.36) | GCGR | |
| SCHEMBL2647808 | 0.81 | GCGR (0.38) | GCGHIF1AGCGRADCY6ADCY3 | |
| SCHEMBL6913810 | 0.71 | CTNNB1 (0.38) | GCGHIF1APPARGHDAC3HDAC4 | |
| SCHEMBL6913803 | 0.71 | CTNNB1 (0.38) | GCGHIF1APPARGHDAC3HDAC4 | |
| SCHEMBL2647432 | 0.70 | GCG (0.54) | GCGHIF1APPARGHDAC3HDAC4 | |
| SCHEMBL2647438 | 0.70 | GCG (0.54) | GCGHIF1APPARGHDAC3HDAC4 | |
| SCHEMBL2647948 | 0.69 | GCGR (0.48) | GCGPPARGHDAC3HDAC4HDAC1 | |
| SCHEMBL2665067 | 0.69 | GCGR (0.55) | GCGRADCY6ADCY3ADCY9ADCY5 | |
| SCHEMBL2647947 | 0.69 | GCGR (0.48) | GCGPPARGHDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6762318-B2 | CARBOXYLIC ACID OR TETRAZOLE DERIVATIZED SECONDARY AMIDES; ORAL ADMINISTRATION | NOVO NORDISK A/S (DK) | 2004-07-13 | — | — | US | disclosed |
| US-20030236292-A1 | Stimulant releasing glucose from liver cells; antidiabetic agents | PFIZER INC | 2003-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236292-A1 | Stimulant releasing glucose from liver cells; antidiabetic agents | GPR119, GLP1R, GIPR | GCG 7/4885HIF1A 2406/4885PPARG 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.